Maynard Um
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) halted, news pending
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) PT Raised to $7.50 at Jefferies
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 5c ; Offers Guidance
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) Confirms Receipt of $8/sh Non-Binding Proposal from Cycle Group Holdings
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

